EYES - Second Sight Medical secures $50M capital via equity raise
Mark_Kuiken/iStock via Getty Images Second Sight Medical Products (EYES) has priced its public offering of 10M common shares at $5.00/share, for gross proceeds of $50M. Underwriters' over-allotment is an additional 1.5M shares. Net proceeds will be used for for development of the Orion device and general corporate purposes. Closing date is June 25. ThinkEquity, a division of Fordham Financial Management is acting as sole book-running manager. Earlier this month, the company filed to raise $250M in mixed shelf offering. Shares down 14.8% after-hours. Previously: Second Sight Medical proposes capital raise (June 22)
For further details see:
Second Sight Medical secures $50M capital via equity raise